Omar A. Karadaghy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Omar A. Karadaghy has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Andres M. Bur
Department of Otolaryngology – Head and Neck Surgery University of Kansas Medical Center Kansas City Kansas USA
9 shared publications - Allen L. Feng
Harvard Medical School, Boston, USA; Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Boston, USA
3 shared publications - Andrew J. Holcomb
Department of Otolaryngology Nebraska Methodist Health System Omaha Nebraska USA
2 shared publications - Bryan Renslo
Department of Otolaryngology- Head and Neck Surgery, University of Kansas Medical Center, Kansas City, KS
2 shared publications Derrick T. Lin
Department of Otolaryngology – Head and Neck Surgery Harvard Medical School Boston Massachusetts USA
2 shared publications- Edward S. Sim
Department of Otolaryngology Massachusetts Eye and Ear Boston Massachusetts USA
2 shared publications
Latest Publications
- 2 February 2026
- Published by Wiley in Head & Neck
- Vol. 48 (7) , 1693-1701
Donor Site Morbidity of Lower Extremity Free Flaps After Reconstructive Surgery of the Head and Neck, a Single‐Center Retrospective Cohort Study
Background: This study aimed to compare donor‐site morbidity among three common major lower extremity free flaps: fibula (FFF), anterolateral thigh (ALT), and the medial sural perforator (MSAP) using an established patient‐reported outcome measure (PROM), the Lower Extremity Functional Scale (LEFS). Methods: Patients who underwent head and neck reconstruction with either FFF, MSAP, or ALT were included. The primary outcome was functional recovery, assessed using the modified LEFS, a PROM measuring functional status, administered at multiple post‐operative timepoints. Results: Seventy‐five patients were included in the analysis: 33 FFF, 22 MSAP and 20 ALT. Patients undergoing lower extremity free flap surgery overall recovered well. The LEFS scores at different time points demonstrated quicker recovery for the MSAP group, while ALT and FFF recovered later. After 360 days, the MSAP group also demonstrated improved functional outcomes compared to the ALT and FFF. Conclusion: Patients undergoing lower extremity free flap surgery recover well. The MSAP had the least donor‐site morbidity. Donor‐site morbidity should be considered when counseling patients.
- 2 February 2026
- Published by Wiley in Head & Neck
- Vol. 48 (7) , 1693-1701
Donor Site Morbidity of Lower Extremity Free Flaps After Reconstructive Surgery of the Head and Neck, a Single‐Center Retrospective Cohort Study
Background: This study aimed to compare donor‐site morbidity among three common major lower extremity free flaps: fibula (FFF), anterolateral thigh (ALT), and the medial sural perforator (MSAP) using an established patient‐reported outcome measure (PROM), the Lower Extremity Functional Scale (LEFS). Methods: Patients who underwent head and neck reconstruction with either FFF, MSAP, or ALT were included. The primary outcome was functional recovery, assessed using the modified LEFS, a PROM measuring functional status, administered at multiple post‐operative timepoints. Results: Seventy‐five patients were included in the analysis: 33 FFF, 22 MSAP and 20 ALT. Patients undergoing lower extremity free flap surgery overall recovered well. The LEFS scores at different time points demonstrated quicker recovery for the MSAP group, while ALT and FFF recovered later. After 360 days, the MSAP group also demonstrated improved functional outcomes compared to the ALT and FFF. Conclusion: Patients undergoing lower extremity free flap surgery recover well. The MSAP had the least donor‐site morbidity. Donor‐site morbidity should be considered when counseling patients.
- 9 May 2025
- Published by Wiley in Head & Neck
Donor Site Morbidity of the Medial Sural Artery Perforator (MSAP) Free Flap for Head & Neck Reconstruction
Background: Minimal donor site morbidity is often cited as one of the main advantages of the medial sural artery perforator (MSAP) free flap; however, few studies have examined functional outcomes.Methods: This retrospective cohort study analyzed patients undergoing MSAP for head and neck reconstruction from 2022 to 2024. A modified lower extremity functional scale (LEFS), with 80 being a maximum score, was administered to assess functional morbidity.Results: Twenty two patients underwent successful MSAP flap. At < 1 month after surgery, the average LEFS was 56.0 (95% CI, 43.8–68.2). At 1–3 months, the average score was 63.0 (95% CI, 56.0–70.0); at 3–6 months, it was 75.0 (95% CI, 70.0–80.0), and at 6–12 months, it was 78.1 (95% CI, 75.4–80.0). Beyond 12 months, the average score was 79.8 (95% CI, 79.8–80.0).Conclusions and Relevance: The MSAP free flap is an excellent free tissue option for head & neck reconstruction with minimal donor site morbidity.
- 9 May 2025
- Published by Wiley in Head & Neck
Donor Site Morbidity of the Medial Sural Artery Perforator (MSAP) Free Flap for Head & Neck Reconstruction
Background: Minimal donor site morbidity is often cited as one of the main advantages of the medial sural artery perforator (MSAP) free flap; however, few studies have examined functional outcomes.Methods: This retrospective cohort study analyzed patients undergoing MSAP for head and neck reconstruction from 2022 to 2024. A modified lower extremity functional scale (LEFS), with 80 being a maximum score, was administered to assess functional morbidity.Results: Twenty two patients underwent successful MSAP flap. At < 1 month after surgery, the average LEFS was 56.0 (95% CI, 43.8–68.2). At 1–3 months, the average score was 63.0 (95% CI, 56.0–70.0); at 3–6 months, it was 75.0 (95% CI, 70.0–80.0), and at 6–12 months, it was 78.1 (95% CI, 75.4–80.0). Beyond 12 months, the average score was 79.8 (95% CI, 79.8–80.0).Conclusions and Relevance: The MSAP free flap is an excellent free tissue option for head & neck reconstruction with minimal donor site morbidity.
- 8 April 2025
- Published by Wiley in Head & Neck
- Vol. 47 (10) , E106-E108
Stomal Bleeding in a Laryngectomized Patient as a Consequence of an Infected Innominate Artery Stent: A Case Report
Background: Laryngectomized patients can present with stomal bleeding for a variety of etiologies that all warrant urgent evaluation and management.Methods: Here, we report a case of a patient who presented with large volume stomal bleeding at least three decades following her total laryngectomy for a dysfunctional larynx secondary to adjuvant radiation therapy she received for thyroid cancer. Her radiation therapy was also complicated by severe stenosis of her innominate‐carotid artery system requiring multiple vascular interventions ultimately leading to calcified and infected arterial stents. On presentation, a tracheoscopy demonstrated an ulcerated area in the anterior tracheal wall. During the diagnostic workup for this patient, it became apparent that there was no blood flow through the distal portion of her innominate artery and that a trachea‐innominate fistula, although high on the differential, was not the source of her stomal bleeding. Her clinical presentation was also complicated by bacteremia of unknown etiology.Results: The patient ultimately underwent surgical exploration to remove the diseased portion of her tracheostoma and an infected innominate arterial stent abutting the tracheal wall. Stomal reconstruction then took place with no further bleeding episodes postoperatively. Pathologic evaluation of the resected fibrotic tissue demonstrated bacterial species and evidence of chronic inflammation.Conclusion: Stomal bleeding in a laryngectomized patient should be evaluated promptly as consequences could be fatal. Although evaluation for major vessel compromise is paramount, other etiologies warrant consideration. Compromised stents of adjacent vasculature should be considered as a potential etiology in the diagnostic evaluation and management of stomal bleeding.
- 8 April 2025
- Published by Wiley in Head & Neck
- Vol. 47 (10) , E106-E108
Stomal Bleeding in a Laryngectomized Patient as a Consequence of an Infected Innominate Artery Stent: A Case Report
Background: Laryngectomized patients can present with stomal bleeding for a variety of etiologies that all warrant urgent evaluation and management.Methods: Here, we report a case of a patient who presented with large volume stomal bleeding at least three decades following her total laryngectomy for a dysfunctional larynx secondary to adjuvant radiation therapy she received for thyroid cancer. Her radiation therapy was also complicated by severe stenosis of her innominate‐carotid artery system requiring multiple vascular interventions ultimately leading to calcified and infected arterial stents. On presentation, a tracheoscopy demonstrated an ulcerated area in the anterior tracheal wall. During the diagnostic workup for this patient, it became apparent that there was no blood flow through the distal portion of her innominate artery and that a trachea‐innominate fistula, although high on the differential, was not the source of her stomal bleeding. Her clinical presentation was also complicated by bacteremia of unknown etiology.Results: The patient ultimately underwent surgical exploration to remove the diseased portion of her tracheostoma and an infected innominate arterial stent abutting the tracheal wall. Stomal reconstruction then took place with no further bleeding episodes postoperatively. Pathologic evaluation of the resected fibrotic tissue demonstrated bacterial species and evidence of chronic inflammation.Conclusion: Stomal bleeding in a laryngectomized patient should be evaluated promptly as consequences could be fatal. Although evaluation for major vessel compromise is paramount, other etiologies warrant consideration. Compromised stents of adjacent vasculature should be considered as a potential etiology in the diagnostic evaluation and management of stomal bleeding.
- 21 March 2025
- Published by Wiley in Head & Neck
- Vol. 47 (8) , 2201-2208
Early Experience With Indocyanine Green (ICG) Fluorescent Guided Transoral Robotic Surgery With the Da Vinci SP
Importance: Carcinoma of Unknown Primary (CUP) presents a clinical challenge for practitioners. The current diagnostic approach often involves extensive imaging and examinations, with variable success. We aimed to evaluate the effectiveness of Indocyanine Green (ICG) injection using the Da Vinci robot to aid in intraoperative decision making.Objectives: To evaluate the diagnostic utility of ICG use during robotic surgery to aid in either the identification of the primary tumor or to delineate the extent of disease to guide excision.Methods: This study involved a retrospective review of patients treated at the Massachusetts Eye and Ear who underwent robotic surgery with the utilization of Indocyanine Green (ICG) from October 1, 2022. All patients in the study were operated on using the SP model of the Da Vinci robot. Basic demographic and pathologic data were recorded. Intraoperative data points included assessing the presence of an identifiable primary tumor using white light only and documenting the confidence level of ICG localization.Results: In total, 28 patients who underwent robotic surgery using ICG were identified for this study. The mean age of the cohort was 62 years. Twenty‐six patients were male, and the primary diagnosis was HPV‐related squamous cell carcinoma (SCCa) in 22 patients, HPV‐negative SCC in 5 patients, atypia in 1 patient, and metastatic papillary thyroid carcinoma in 1 patient. Nine patients had either PET‐localizing or visually identified primary tumors, and ICG was used to guide the surgical extent of resection. The remaining 19 patients had CUP. Within the patients with CUP, the primary was ultimately identified in 16 of the 19 (84.2%) patients. In regard to ICG localization, this resulted in a True Positive detection in 10 patients (52.6%), False Positive detection in 6 patients (31.6%), False Negative detection in 0 patients (0%), and True Negative detection in 3 patients (15.8%). Based on a confusion matrix of the aforementioned values, the calculated sensitivity, specificity, PPV, and NPV were 100%, 33.3%, 62.5%, and 100%, respectively. The discriminatory index of ICG in the detection of unknown primary disease was found to be 66.6%.Conclusion: The integration of systemic ICG injection with the Da Vinci SP robot's real‐time imaging capabilities offers a potential option for enhancing primary tumor identification in CUP patients that adds little to no cost, time, and morbidity to the patient. This preliminary analysis suggests that the use of ICG in robotic surgery for CUP holds promise and warrants further investigation to refine surgical techniques and enhance clinical outcomes.
- 21 March 2025
- Published by Wiley in Head & Neck
- Vol. 47 (8) , 2201-2208
Early Experience With Indocyanine Green (ICG) Fluorescent Guided Transoral Robotic Surgery With the Da Vinci SP
Importance: Carcinoma of Unknown Primary (CUP) presents a clinical challenge for practitioners. The current diagnostic approach often involves extensive imaging and examinations, with variable success. We aimed to evaluate the effectiveness of Indocyanine Green (ICG) injection using the Da Vinci robot to aid in intraoperative decision making.Objectives: To evaluate the diagnostic utility of ICG use during robotic surgery to aid in either the identification of the primary tumor or to delineate the extent of disease to guide excision.Methods: This study involved a retrospective review of patients treated at the Massachusetts Eye and Ear who underwent robotic surgery with the utilization of Indocyanine Green (ICG) from October 1, 2022. All patients in the study were operated on using the SP model of the Da Vinci robot. Basic demographic and pathologic data were recorded. Intraoperative data points included assessing the presence of an identifiable primary tumor using white light only and documenting the confidence level of ICG localization.Results: In total, 28 patients who underwent robotic surgery using ICG were identified for this study. The mean age of the cohort was 62 years. Twenty‐six patients were male, and the primary diagnosis was HPV‐related squamous cell carcinoma (SCCa) in 22 patients, HPV‐negative SCC in 5 patients, atypia in 1 patient, and metastatic papillary thyroid carcinoma in 1 patient. Nine patients had either PET‐localizing or visually identified primary tumors, and ICG was used to guide the surgical extent of resection. The remaining 19 patients had CUP. Within the patients with CUP, the primary was ultimately identified in 16 of the 19 (84.2%) patients. In regard to ICG localization, this resulted in a True Positive detection in 10 patients (52.6%), False Positive detection in 6 patients (31.6%), False Negative detection in 0 patients (0%), and True Negative detection in 3 patients (15.8%). Based on a confusion matrix of the aforementioned values, the calculated sensitivity, specificity, PPV, and NPV were 100%, 33.3%, 62.5%, and 100%, respectively. The discriminatory index of ICG in the detection of unknown primary disease was found to be 66.6%.Conclusion: The integration of systemic ICG injection with the Da Vinci SP robot's real‐time imaging capabilities offers a potential option for enhancing primary tumor identification in CUP patients that adds little to no cost, time, and morbidity to the patient. This preliminary analysis suggests that the use of ICG in robotic surgery for CUP holds promise and warrants further investigation to refine surgical techniques and enhance clinical outcomes.
- 19 March 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 173 (1) , 106-114
Impact of Margins on Outcomes in HPV‐Related Oropharyngeal Squamous Cell Carcinoma Treated With Surgery Only
Objective: This study aims to evaluate the prognostic impact of surgical margin status in HPV‐related oropharyngeal squamous cell carcinoma (OPSCCa) and examine the potential for revising surgical margin standards in HPV+ OPSCCa.Study Design: A retrospective cohort study.Setting: This study was conducted across 4 tertiary oncology centers.Methods: Charts of patients treated from 2010 to 2022 for HPV+ OPSCCa were reviewed. Eligible patients underwent surgery without adjuvant treatment for nonrecurrent, nonmetastatic HPV+ OPSCCa. Demographic, oncologic, treatment, and outcome data were collected. Patients with prior head and neck radiation or adjuvant therapy were excluded. Local control, locoregional recurrence (LRR), disease‐free survival (DFS), and overall survival (OS) were compared based on surgical margins using the Kaplan–Meier method.Results: Among 194 qualified cases, with a median follow‐up of 41.63 months, most cases were pT1 (64.43%) or pT2 (34.54%). Recurrence occurred in 8.76% of patients, with most salvaged successfully. Analysis on univariable and multivariable modeling determined that margins less than 1 mm were considered close, and those ≥1 mm were considered clear. On multivariable modeling, surgical margins of <1 mm were associated with a hazard ratio of 3.69 (95% confidence interval [CI] 1.47‐9.30) for LRR and 2.95 (95% CI 1.41‐6.16) for DFS when compared to cases where margins were clear by 1 mm or greater.Conclusion: In this multi‐institutional cohort of early‐stage HPV+ OPSCCa treated surgically without adjuvant therapy, margins <1 mm were associated with worse LRR and DFS. This suggests that traditional definitions of close margins in HPV‐negative disease may not apply to HPV+ OPSCCa, warranting a revised definition for surgical margin standards.
- 19 March 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 173 (1) , 106-114
Impact of Margins on Outcomes in HPV‐Related Oropharyngeal Squamous Cell Carcinoma Treated With Surgery Only
Objective: This study aims to evaluate the prognostic impact of surgical margin status in HPV‐related oropharyngeal squamous cell carcinoma (OPSCCa) and examine the potential for revising surgical margin standards in HPV+ OPSCCa.Study Design: A retrospective cohort study.Setting: This study was conducted across 4 tertiary oncology centers.Methods: Charts of patients treated from 2010 to 2022 for HPV+ OPSCCa were reviewed. Eligible patients underwent surgery without adjuvant treatment for nonrecurrent, nonmetastatic HPV+ OPSCCa. Demographic, oncologic, treatment, and outcome data were collected. Patients with prior head and neck radiation or adjuvant therapy were excluded. Local control, locoregional recurrence (LRR), disease‐free survival (DFS), and overall survival (OS) were compared based on surgical margins using the Kaplan–Meier method.Results: Among 194 qualified cases, with a median follow‐up of 41.63 months, most cases were pT1 (64.43%) or pT2 (34.54%). Recurrence occurred in 8.76% of patients, with most salvaged successfully. Analysis on univariable and multivariable modeling determined that margins less than 1 mm were considered close, and those ≥1 mm were considered clear. On multivariable modeling, surgical margins of <1 mm were associated with a hazard ratio of 3.69 (95% confidence interval [CI] 1.47‐9.30) for LRR and 2.95 (95% CI 1.41‐6.16) for DFS when compared to cases where margins were clear by 1 mm or greater.Conclusion: In this multi‐institutional cohort of early‐stage HPV+ OPSCCa treated surgically without adjuvant therapy, margins <1 mm were associated with worse LRR and DFS. This suggests that traditional definitions of close margins in HPV‐negative disease may not apply to HPV+ OPSCCa, warranting a revised definition for surgical margin standards.
- 20 December 2024
- Published by Wiley in Head & Neck
- Vol. 47 (2) , 776-782
Single Stage Reconstruction of Composite Rhinectomy Defects Using Osteocutaneous Radial Forearm Free Flap
Background: Composite rhinectomy defects pose significant challenges due to the nose's complex structure and role in facial esthetics and function. Traditional nasal reconstructions often require multiple stages to restore mucosal lining, structural support, and external skin.Methods: This case series examines the use of a single‐stage osteocutaneous radial forearm free flap (OCRFFF) for composite rhinectomy reconstruction. Three patients who underwent composite rhinectomy due to malignancy were treated using OCRFFF, which allows for simultaneous reconstruction of composite nasal defects by incorporating skin, bone, and fascial tissue.Results: All three cases achieved successful postoperative outcomes, demonstrating both cosmetic and functional success without significant long‐term complications. The single‐stage approach streamlined the reconstructive process, reducing patient recovery time and the need for additional surgeries.Conclusions: OCRFFF is an effective, transformative technique for single‐stage nasal reconstruction for composite rhinectomy defects, providing reliable functional and esthetic outcomes, and contributing to advancements in complex nasal defect management.
- 20 December 2024
- Published by Wiley in Head & Neck
- Vol. 47 (2) , 776-782
Single Stage Reconstruction of Composite Rhinectomy Defects Using Osteocutaneous Radial Forearm Free Flap
Background: Composite rhinectomy defects pose significant challenges due to the nose's complex structure and role in facial esthetics and function. Traditional nasal reconstructions often require multiple stages to restore mucosal lining, structural support, and external skin.Methods: This case series examines the use of a single‐stage osteocutaneous radial forearm free flap (OCRFFF) for composite rhinectomy reconstruction. Three patients who underwent composite rhinectomy due to malignancy were treated using OCRFFF, which allows for simultaneous reconstruction of composite nasal defects by incorporating skin, bone, and fascial tissue.Results: All three cases achieved successful postoperative outcomes, demonstrating both cosmetic and functional success without significant long‐term complications. The single‐stage approach streamlined the reconstructive process, reducing patient recovery time and the need for additional surgeries.Conclusions: OCRFFF is an effective, transformative technique for single‐stage nasal reconstruction for composite rhinectomy defects, providing reliable functional and esthetic outcomes, and contributing to advancements in complex nasal defect management.
- 26 July 2024
- Published by Wiley in Head & Neck
- Vol. 47 (1) , 34-46
Prognostic significance of hemorrhage requiring embolization in the setting of previously treated head and neck squamous cell carcinoma: Systematic review and retrospective cohort
Background: The management of acute hemorrhage in patients with previously treated head and neck squamous cell carcinoma (HNSCC) is challenging due to the lack of substantial evidence to guide clinical decision making.Methods: A systematic review and retrospective chart review were performed to identify patients with a history of HNSCC who underwent either primary or adjuvant radiation therapy (RT) and presented with hemorrhagic complications requiring embolization. Patient characteristics, history, presentation, and outcomes were reviewed.Results: The systematic review included a total of 182 patients. Heterogeneity existed in outcomes reporting; 1‐year overall survival approached 50%. From the retrospective chart review, 51 patients were included. Median survival time following hemorrhage was 2.2 months (range 1.2–11.4 months). Patients with malignancy at time of hemorrhage were identified as having worse survival.Conclusions: Acute hemorrhage in patients with a history of previously radiated HNSCC portends a high risk of mortality, with patients with active malignancy representing a worse prognostic group.
- 26 July 2024
- Published by Wiley in Head & Neck
- Vol. 47 (1) , 34-46
Prognostic significance of hemorrhage requiring embolization in the setting of previously treated head and neck squamous cell carcinoma: Systematic review and retrospective cohort
Background: The management of acute hemorrhage in patients with previously treated head and neck squamous cell carcinoma (HNSCC) is challenging due to the lack of substantial evidence to guide clinical decision making.Methods: A systematic review and retrospective chart review were performed to identify patients with a history of HNSCC who underwent either primary or adjuvant radiation therapy (RT) and presented with hemorrhagic complications requiring embolization. Patient characteristics, history, presentation, and outcomes were reviewed.Results: The systematic review included a total of 182 patients. Heterogeneity existed in outcomes reporting; 1‐year overall survival approached 50%. From the retrospective chart review, 51 patients were included. Median survival time following hemorrhage was 2.2 months (range 1.2–11.4 months). Patients with malignancy at time of hemorrhage were identified as having worse survival.Conclusions: Acute hemorrhage in patients with a history of previously radiated HNSCC portends a high risk of mortality, with patients with active malignancy representing a worse prognostic group.
- 20 May 2024
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 171 (3) , 756-763
Functional Oral Intake in Primary Versus Salvage Laryngectomy
Objective: Advanced‐stage laryngeal squamous cell carcinoma is treated with primary surgery or chemoradiation. We aim to determine if there are differences in postoperative functional oral intake in primary (PL) versus salvage laryngectomees (SL).Study Design: Retrospective cohort study.Setting: Patients who underwent laryngectomy between 2011 and 2021.Methods: We examined demographic, diagnostic, treatment, and swallow function data pre‐ and postoperatively. A follow‐up survey was distributed to assess current swallow status.Results: One hundred twenty‐five patients were included. Preoperatively, 68.8% of patients reported dysphagia. Median functional oral intake score (FOIS) was 4.0 [interquartile range, IQR: 1.0‐6.75]. The SL group had lower preop FOIS [2.0; IQR: 1.0‐4.75] that did not reach significance compared to the PL group [4.5; IQR: 1.0‐7.0] (P = .052). 73.4% of patients had a feeding tube. The PL group was more likely to have the tube removed [odds ratio, OR: 2.4; confidence interval, CI: 1.0‐5.7]. The SL group was more likely to require feeding tube placement more than 6 months postop [OR: 6.9; CI: 1.65‐32.6]. SL FOIS scores improved by 3 months postop to 5 (SL ΔFOIS = 3, P = .0150). PL scores improved to 7 [PL ΔFOIS = 2, P = .0005] at 12 to 15 months. Sixty‐nine patients were contacted for a follow‐up survey and 16 completed this survey. 30.4% patients reported dietary restrictions (mean 4.4 years postop).Conclusion: Patients undergoing SL appear to obtain similar swallow outcomes compared to PL at 3 to 6 months postlaryngectomy, but plateau. The PL group continues to improve up to 1 year postoperatively. Fifty percent of patients report on‐going dysphagia after 5 years.
- 20 May 2024
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 171 (3) , 756-763
Functional Oral Intake in Primary Versus Salvage Laryngectomy
Objective: Advanced‐stage laryngeal squamous cell carcinoma is treated with primary surgery or chemoradiation. We aim to determine if there are differences in postoperative functional oral intake in primary (PL) versus salvage laryngectomees (SL).Study Design: Retrospective cohort study.Setting: Patients who underwent laryngectomy between 2011 and 2021.Methods: We examined demographic, diagnostic, treatment, and swallow function data pre‐ and postoperatively. A follow‐up survey was distributed to assess current swallow status.Results: One hundred twenty‐five patients were included. Preoperatively, 68.8% of patients reported dysphagia. Median functional oral intake score (FOIS) was 4.0 [interquartile range, IQR: 1.0‐6.75]. The SL group had lower preop FOIS [2.0; IQR: 1.0‐4.75] that did not reach significance compared to the PL group [4.5; IQR: 1.0‐7.0] (P = .052). 73.4% of patients had a feeding tube. The PL group was more likely to have the tube removed [odds ratio, OR: 2.4; confidence interval, CI: 1.0‐5.7]. The SL group was more likely to require feeding tube placement more than 6 months postop [OR: 6.9; CI: 1.65‐32.6]. SL FOIS scores improved by 3 months postop to 5 (SL ΔFOIS = 3, P = .0150). PL scores improved to 7 [PL ΔFOIS = 2, P = .0005] at 12 to 15 months. Sixty‐nine patients were contacted for a follow‐up survey and 16 completed this survey. 30.4% patients reported dietary restrictions (mean 4.4 years postop).Conclusion: Patients undergoing SL appear to obtain similar swallow outcomes compared to PL at 3 to 6 months postlaryngectomy, but plateau. The PL group continues to improve up to 1 year postoperatively. Fifty percent of patients report on‐going dysphagia after 5 years.
- Open Access
- 15 September 2023
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 29 (18_Supplem) , PO-043-043
Abstract PO-043: Development of an automated multi-objective model utilizing delta radiomics to predict locoregional recurrence in head and neck cancer patients treated with primary radiation
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer globally and is frequently treated with definitive radiotherapy. However, 15-50% of patients experience locoregional recurrence (LRR) within 3 years of treatment. The majority of recurrences develop within the first 2 years. Machine learning and deep learning have been utilized to predict oncologic treatment outcomes with high accuracy. Accurate prediction allows for the identification of high-risk patients prior to recurrence, allowing for more intensified monitoring and increased likelihood of long-term disease control. Radiomics is the extraction of quantitative data from radiologic images and provides information that is imperceptible to the human eye. Prior studies have successfully utilized pre- or post-treatment contrast enhanced CT (CECT) images to predict treatment outcomes in HNSCC in machine learning models. In this study, we utilize pre-treatment CECT radiomic features to build an automated multi-objective (AutoMO) model to predict LRR for patients with HNSCC treated with definitive radiotherapy. Patients with primary laryngeal, oropharyngeal, or hypopharyngeal cancer treated with primary radiotherapy from January 2018 through November 2020 were identified. Patients were excluded if they did not have a pre-treatment CECT within 3 months of initiation or a post-treatment CECT within 1-6 months of completion of radiotherapy. Pre- and post-treatment CECT scans as well as clinical information, including locoregional recurrence or progression within two years, were collected retrospectively. Pre-treatment CECT scans contoured for gross tumor volume (GTV) were also collected, which were utilized as the ground-truth reference for auto-contouring of pre-treatment scans. An AutoMO model was developed that maximizes both sensitivity and specificity simultaneously, offering more balanced results as compared to a model that reports the traditional area under the curve (AUC) metric. Following CECT image pre-processing, 275 radiomic features including intensity, texture and geometry were extracted in 3-dimensional volume from pre-treatment CECT scans. Image features were fed into the AutoMO model. 3-fold cross validation was performed, and hyperparameters were tuned to optimize model results. A total of 70 patients met inclusion criteria. The population was 81.4% male (n=57) with an average age of 64.4. Of all patients 22 (31.4%) were positive for recurrence or progression. The model achieved a sensitivity of 0.55, specificity of 0.83, accuracy of 0.79, and AUC of 0.65. The AutoMO model was moderately accurate for predicting recurrence or progression for patients with HNSCC utilizing pre-treatment CECT radiomics. Future iterations integrating clinical data, post-treatment images, and an increased sample size should improve model accuracy. Citation Format: Bryan Renslo, Ethan Kallenberger, Patrick Ioerger, Kenny Guida, Oluwatobiloba Ige, Omar Karadaghy, Gregory Gan, Zhiguo Zhou, Andres Bur. Development of an automated multi-objective model utilizing delta radiomics to predict locoregional recurrence in head and neck cancer patients treated with primary radiation [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Innovating through Basic, Clinical, and Translational Research; 2023 Jul 7-8; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2023;29(18_Suppl):Abstract nr PO-043.
- 15 September 2023
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 29 (18_Supplem) , PO-043-043
Open AccessAbstract PO-043: Development of an automated multi-objective model utilizing delta radiomics to predict locoregional recurrence in head and neck cancer patients treated with primary radiation
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer globally and is frequently treated with definitive radiotherapy. However, 15-50% of patients experience locoregional recurrence (LRR) within 3 years of treatment. The majority of recurrences develop within the first 2 years. Machine learning and deep learning have been utilized to predict oncologic treatment outcomes with high accuracy. Accurate prediction allows for the identification of high-risk patients prior to recurrence, allowing for more intensified monitoring and increased likelihood of long-term disease control. Radiomics is the extraction of quantitative data from radiologic images and provides information that is imperceptible to the human eye. Prior studies have successfully utilized pre- or post-treatment contrast enhanced CT (CECT) images to predict treatment outcomes in HNSCC in machine learning models. In this study, we utilize pre-treatment CECT radiomic features to build an automated multi-objective (AutoMO) model to predict LRR for patients with HNSCC treated with definitive radiotherapy. Patients with primary laryngeal, oropharyngeal, or hypopharyngeal cancer treated with primary radiotherapy from January 2018 through November 2020 were identified. Patients were excluded if they did not have a pre-treatment CECT within 3 months of initiation or a post-treatment CECT within 1-6 months of completion of radiotherapy. Pre- and post-treatment CECT scans as well as clinical information, including locoregional recurrence or progression within two years, were collected retrospectively. Pre-treatment CECT scans contoured for gross tumor volume (GTV) were also collected, which were utilized as the ground-truth reference for auto-contouring of pre-treatment scans. An AutoMO model was developed that maximizes both sensitivity and specificity simultaneously, offering more balanced results as compared to a model that reports the traditional area under the curve (AUC) metric. Following CECT image pre-processing, 275 radiomic features including intensity, texture and geometry were extracted in 3-dimensional volume from pre-treatment CECT scans. Image features were fed into the AutoMO model. 3-fold cross validation was performed, and hyperparameters were tuned to optimize model results. A total of 70 patients met inclusion criteria. The population was 81.4% male (n=57) with an average age of 64.4. Of all patients 22 (31.4%) were positive for recurrence or progression. The model achieved a sensitivity of 0.55, specificity of 0.83, accuracy of 0.79, and AUC of 0.65. The AutoMO model was moderately accurate for predicting recurrence or progression for patients with HNSCC utilizing pre-treatment CECT radiomics. Future iterations integrating clinical data, post-treatment images, and an increased sample size should improve model accuracy. Citation Format: Bryan Renslo, Ethan Kallenberger, Patrick Ioerger, Kenny Guida, Oluwatobiloba Ige, Omar Karadaghy, Gregory Gan, Zhiguo Zhou, Andres Bur. Development of an automated multi-objective model utilizing delta radiomics to predict locoregional recurrence in head and neck cancer patients treated with primary radiation [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Innovating through Basic, Clinical, and Translational Research; 2023 Jul 7-8; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2023;29(18_Suppl):Abstract nr PO-043.
- 23 June 2023
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 169 (6) , 1564-1572
Interpretable Computer Vision to Detect and Classify Structural Laryngeal Lesions in Digital Flexible Laryngoscopic Images
Objective: To localize structural laryngeal lesions within digital flexible laryngoscopic images and to classify them as benign or suspicious for malignancy using state‐of‐the‐art computer vision detection models.Study Design: Cross‐sectional diagnostic studySetting: Tertiary care voice clinicMethods: Digital stroboscopic videos, demographic and clinical data were collected from patients evaluated for a structural laryngeal lesion. Laryngoscopic images were extracted from videos and manually labeled with bounding boxes encompassing the lesion. Four detection models were employed to simultaneously localize and classify structural laryngeal lesions in laryngoscopic images. Classification accuracy, intersection over union (IoU) and mean average precision (mAP) were evaluated as measures of classification, localization, and overall performance, respectively.Results: In total, 8,172 images from 147 patients were included in the laryngeal image dataset. Classification accuracy was 88.5 for individual laryngeal images and increased to 92.0 when all images belonging to the same sequence (video) were considered. Mean average precision across all four detection models was 50.1 using an IoU threshold of 0.5 to determine successful localization.Conclusion: Results of this study showed that deep neural network‐based detection models trained using a labeled dataset of digital laryngeal images have the potential to classify structural laryngeal lesions as benign or suspicious for malignancy and to localize them within an image. This approach provides valuable insight into which part of the image was used by the model to determine a diagnosis, allowing clinicians to independently evaluate models' predictions.
- 23 June 2023
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 169 (6) , 1564-1572
Interpretable Computer Vision to Detect and Classify Structural Laryngeal Lesions in Digital Flexible Laryngoscopic Images
Objective: To localize structural laryngeal lesions within digital flexible laryngoscopic images and to classify them as benign or suspicious for malignancy using state‐of‐the‐art computer vision detection models.Study Design: Cross‐sectional diagnostic studySetting: Tertiary care voice clinicMethods: Digital stroboscopic videos, demographic and clinical data were collected from patients evaluated for a structural laryngeal lesion. Laryngoscopic images were extracted from videos and manually labeled with bounding boxes encompassing the lesion. Four detection models were employed to simultaneously localize and classify structural laryngeal lesions in laryngoscopic images. Classification accuracy, intersection over union (IoU) and mean average precision (mAP) were evaluated as measures of classification, localization, and overall performance, respectively.Results: In total, 8,172 images from 147 patients were included in the laryngeal image dataset. Classification accuracy was 88.5 for individual laryngeal images and increased to 92.0 when all images belonging to the same sequence (video) were considered. Mean average precision across all four detection models was 50.1 using an IoU threshold of 0.5 to determine successful localization.Conclusion: Results of this study showed that deep neural network‐based detection models trained using a labeled dataset of digital laryngeal images have the potential to classify structural laryngeal lesions as benign or suspicious for malignancy and to localize them within an image. This approach provides valuable insight into which part of the image was used by the model to determine a diagnosis, allowing clinicians to independently evaluate models' predictions.